儿童及青少年哮喘与SARS-CoV-2感染风险的关系
这项回顾性队列研究纳入46 900名5至17岁儿童,其中13.5%符合哮喘标准,通过倾向性评分1:1匹配后分析哮喘与SARS-CoV-2感染风险的关联。在匹配队列中,哮喘与非哮喘儿童的感染阳性率均为2.8%,风险比为0.98(95%CI 0.85-1.13),表明控制检测因素后哮喘儿童感染风险与无哮喘儿童相似。
要点
- 哮喘儿童接受SARS-CoV-2检测的比例高于无哮喘儿童(33.0% vs 20.9%)。
- 匹配队列中哮喘与无哮喘儿童感染阳性率均为2.8%,风险比0.98(95%CI 0.85-1.13)。
- 吸入性糖皮质激素处方、严重急性发作史或特应性疾病史未改变哮喘与感染风险的关联。
核心结论
- 控制SARS-CoV-2检测相关因素后,哮喘儿童与无哮喘儿童的SARS-CoV-2感染风险相似。
研究设计与样本
- 回顾性队列研究,纳入46 900名5至17岁在杜克大学卫生系统接受医疗且有达勒姆县住址的儿童。
- 使用经过验证的电子健康记录定义分类哮喘,基于2020年3月1日至2021年9月30日呼吸道样本PCR阳性识别SARS-CoV-2感染。
- 采用倾向性评分1:1匹配哮喘与非哮喘儿童,使用泊松回归评估关联。
主要发现
- 46 900名儿童中6324名(13.5%)符合哮喘标准。
- 哮喘儿童接受SARS-CoV-2检测的比例为33.0%,无哮喘儿童为20.9%(P < .0001)。
- 倾向性评分匹配队列共12 648名儿童,706名(5.6%)SARS-CoV-2检测阳性,其中哮喘儿童350名(2.8%),无哮喘儿童356名(2.8%)。
- 风险比为0.98(95%CI 0.85-1.13),无证据表明吸入性糖皮质激素处方、严重急性发作史或共病特应性疾病对该关联存在效应修饰。
- 仅1名哮喘儿童因SARS-CoV-2感染住院。
临床怎么用
- 哮喘儿童不必因哮喘本身而被视为SARS-CoV-2感染的高风险群体。
- 临床应关注哮喘儿童检测率较高这一现象,避免检测偏倚影响风险评估。
局限性
- 研究为单中心回顾性队列,仅限杜克大学卫生系统及达勒姆县住址儿童。
- 哮喘分类基于电子健康记录定义,可能存在错分。
- 仅1名哮喘儿童因SARS-CoV-2感染住院,住院结局数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Over 6 million pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have occurred in the United States, but risk factors for infection remain poorly defined. We sought to evaluate the association between asthma and SARS-CoV-2 infection risk among children. METHODS: We conducted a retrospective cohort study of children 5 to 17 years of age receiving care through the Duke University Health System and who had a Durham County, North Carolina residential address. Children were classified as having asthma using previously validated electronic health record-based definitions. SARS-CoV-2 infections were identified based on positive polymerase chain reaction testing of respiratory samples collected between March 1, 2020, and September 30, 2021. We matched children with asthma 1:1 to children without asthma, using propensity scores and used Poisson regression to evaluate the association between asthma and SARS-CoV-2 infection risk. RESULTS: Of 46 900 children, 6324 (13.5%) met criteria for asthma. Children with asthma were more likely to be tested for SARS-CoV-2 infection than children without asthma (33.0% vs 20.9%, P < .0001). In a propensity score-matched cohort of 12 648 children, 706 (5.6%) children tested positive for SARS-CoV-2 infection, including 350 (2.8%) children with asthma and 356 (2.8%) children without asthma (risk ratio: 0.98, 95% confidence interval: 0.85-1.13. There was no evidence of effect modification of this association by inhaled corticosteroid prescription, history of severe exacerbation, or comorbid atopic diseases. Only 1 child with asthma required hospitalization for SARS-CoV-2 infection. CONCLUSIONS: After controlling for factors associated with SARS-CoV-2 testing, we found that children with asthma have a similar SARS-CoV-2 infection risk as children without asthma.
引用
- Rao S, Hurst JH, Zhao C, et al. Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents. Pediatrics. 2022. PMID: 35274143. doi:10.1542/peds.2021-056164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。